Sarah Fogarty
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Sarah Fogarty has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- Jared Rutter
Department of Biochemistry, University of Utah, Salt Lake City, USA
2 shared publications - Alex J. Bott
Department of Biochemistry, University of Utah School of Medicine, Salt Lake City, UT, USA
1 shared publication - Catherine Argyriou
Department of Human Genetics, McGill University, Montreal, QC, Canada
1 shared publication - Chelsea U. Kidwell
Department of Biochemistry, University of Utah School of Medicine
1 shared publication - Esther Nuebel
Howard Hughes Medical Institute Salt Lake City UT USA
1 shared publication Geanette Lam
Department of Biochemistry, University of Utah School of Medicine, Salt Lake City, UT, USA
1 shared publication
Latest Publications
- Open Access
Hyperactivation of β-catenin rewires mitochondrial fuel selection in liver cancer cells
Metabolic state is tightly linked to cell fate, and expression of the mitochondrial pyruvate carrier (MPC), which imports pyruvate into mitochondria, is a robust marker of it. The transcriptional regulators that set metabolic state, however, remain poorly defined. In the liver, β-catenin is one of the determinants of metabolic zonation, and activating CTNNB1 mutations are frequent in hepatocellular carcinoma. Here we show that β-catenin regulates metabolic state in liver cancer cells. An unbiased CRISPR screen that uses endogenous MPC1 transcript abundance as the marker identifies CTNNB1 . Activating β-catenin pharmacologically or genetically reduces MPC1 and MPC2 transcript and protein levels, and MPC expression is also low in β-catenin-driven liver tumors in vivo. Beyond the MPC, β-catenin activation impairs assembly of respiratory Complexes III and IV, reduces mitochondrial DNA content and respiratory capacity, elongates mitochondrial networks and remodels the lipidome. Stable isotope tracing shows reduced entry of glucose- and lactate-derived carbon into the TCA cycle alongside increased oxidation of palmitate and oleate. These findings identify β-catenin as a regulator of metabolic state that drives a fuel switch from carbohydrate to fatty acid oxidation in liver cancer cells.
Open AccessHyperactivation of β-catenin rewires mitochondrial fuel selection in liver cancer cells
Metabolic state is tightly linked to cell fate, and expression of the mitochondrial pyruvate carrier (MPC), which imports pyruvate into mitochondria, is a robust marker of it. The transcriptional regulators that set metabolic state, however, remain poorly defined. In the liver, β-catenin is one of the determinants of metabolic zonation, and activating CTNNB1 mutations are frequent in hepatocellular carcinoma. Here we show that β-catenin regulates metabolic state in liver cancer cells. An unbiased CRISPR screen that uses endogenous MPC1 transcript abundance as the marker identifies CTNNB1 . Activating β-catenin pharmacologically or genetically reduces MPC1 and MPC2 transcript and protein levels, and MPC expression is also low in β-catenin-driven liver tumors in vivo. Beyond the MPC, β-catenin activation impairs assembly of respiratory Complexes III and IV, reduces mitochondrial DNA content and respiratory capacity, elongates mitochondrial networks and remodels the lipidome. Stable isotope tracing shows reduced entry of glucose- and lactate-derived carbon into the TCA cycle alongside increased oxidation of palmitate and oleate. These findings identify β-catenin as a regulator of metabolic state that drives a fuel switch from carbohydrate to fatty acid oxidation in liver cancer cells.
- 5 August 2021
- Published by Springer Nature in EMBO Reports
- Vol. 22 (10) , e51991
The biochemical basis of mitochondrial dysfunction in Zellweger Spectrum Disorder
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.
- 5 August 2021
- Published by Springer Nature in EMBO Reports
- Vol. 22 (10) , e51991
The biochemical basis of mitochondrial dysfunction in Zellweger Spectrum Disorder
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.